BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14690163)

  • 1. Stage I and II mobile tongue carcinomas treated by external radiation and gold seed implantation.
    Kimura Y; Fuwa N; Kamata M; Matsumoto A; Nakamura PK; Nakamura T; Ariji E
    Acta Oncol; 2003; 42(7):763-70. PubMed ID: 14690163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy of stage I and II carcinomas of the mobile tongue and/or floor of the mouth.
    Bachaud JM; Delannes M; Allouache N; Benchalal M; Alzieu C; David JM; Serrano E; Daly-Schveitzer NJ
    Radiother Oncol; 1994 Jun; 31(3):199-206. PubMed ID: 8066202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interstitial brachytherapy for stage I and II squamous cell carcinoma of the oral tongue: factors influencing local control and soft tissue complications.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Matsuura K; Ito K
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):767-75. PubMed ID: 10386633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of mandibular bone complications in radiotherapy for T1 and T2 carcinoma of the oral tongue.
    Fujita M; Hirokawa Y; Kashiwado K; Akagi Y; Kashimoto K; Kiriu H; Ohtani K; Wada T
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):333-9. PubMed ID: 8567334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial brachytherapy and neck dissection for Stage III squamous cell carcinoma of the mobile tongue.
    Ihara N; Shibuya H; Yoshimura R; Oota S; Miura M; Watanabe H
    Acta Oncol; 2005; 44(7):709-16. PubMed ID: 16227161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment results of stage I and II oral tongue cancer with interstitial brachytherapy: maximum tumor thickness is prognostic of nodal metastasis.
    Matsuura K; Hirokawa Y; Fujita M; Akagi Y; Ito K
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):535-9. PubMed ID: 9486601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iridium 192 implantation of T1 and T2 carcinomas of the mobile tongue.
    Mazeron JJ; Crook JM; Benck V; Marinello G; Martin M; Raynal M; Haddad E; Peynègre R; Le Bourgeois JP; Walop W
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1369-76. PubMed ID: 2262360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Time, dose and volume factors in interstitial brachytherapy combined with external irradiation for oral tongue carcinoma].
    Yorozu A
    Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Apr; 56(5):303-10. PubMed ID: 8692656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio.
    Lau HY; Hay JH; Flores AD; Threlfall WJ
    Radiother Oncol; 1996 Apr; 39(1):15-8. PubMed ID: 8735489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of the mobile tongue.
    Benk V; Mazeron JJ; Grimard L; Crook J; Haddad E; Piedbois P; Calitchi E; Raynal M; Martin M; Le Bourgeois JP
    Radiother Oncol; 1990 Aug; 18(4):339-47. PubMed ID: 2135735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers.
    Gibbs IC; Le QT; Shah RD; Terris DJ; Fee WE; Goffinet DR
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):489-94. PubMed ID: 12957261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent functional outcome in patients with squamous cell carcinoma of the base of tongue treated with external irradiation and interstitial iodine 125 boost.
    Horwitz EM; Frazier AJ; Martinez AA; Keidan RD; Clarke DH; Lacerna MD; Gustafson GS; Heil E; Dmuchowski CF; Vicini FA
    Cancer; 1996 Sep; 78(5):948-57. PubMed ID: 8780531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachytherapy for stage I & II oral tongue cancer: an analysis of past cases focusing on control and complications.
    Shibuya H; Hoshina M; Takeda M; Matsumoto S; Suzuki S; Okada N
    Int J Radiat Oncol Biol Phys; 1993 Apr; 26(1):51-8. PubMed ID: 8482630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of brachytherapy and surgery for the treatment of stage I-II squamous cell carcinoma of the tongue.
    Umeda M; Komatsubara H; Ojima Y; Minamikawa T; Shibuya Y; Yokoo S; Ishii J; Komori T
    Int J Oral Maxillofac Surg; 2005 Oct; 34(7):739-44. PubMed ID: 15921890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iridium-192 brachytherapy in the management of 147 T2N0 oral tongue carcinomas treated with irradiation alone: comparison of two treatment techniques.
    Pernot M; Malissard L; Aletti P; Hoffstetter S; Forçard JJ; Bey P
    Radiother Oncol; 1992 Apr; 23(4):223-8. PubMed ID: 1609126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
    Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Curietherapy versus external irradiation combined with curietherapy in stage II squamous cell carcinomas of mobile tongue and floor of mouth.
    Mazeron JJ; Grimard L; Benk V
    Recent Results Cancer Res; 1994; 134():101-10. PubMed ID: 8153426
    [No Abstract]   [Full Text] [Related]  

  • 18. Curative brachytherapy for recurrent/residual tongue cancer.
    Ayukawa F; Shibuya H; Yoshimura R; Watanabe H; Miura M
    Strahlenther Onkol; 2007 Mar; 183(3):133-7. PubMed ID: 17340071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ORL brachytherapy. Brachytherapy of epidermoid carcinoma of the oral cavity].
    Haie-Meder C; Marsiglia H; Mamelle G; Wibault P; Lartigau E; Gerbaulet A
    Bull Cancer Radiother; 1995; 82(2):186-90. PubMed ID: 7546889
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary radiotherapy in the treatment of stage I and II oral tongue cancers: importance of the proportion of therapy delivered with interstitial therapy.
    Wendt CD; Peters LJ; Delclos L; Ang KK; Morrison WH; Maor MH; Robbins KT; Byers RM; Carlson LS; Oswald MJ
    Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1287-92. PubMed ID: 2370178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.